• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Auna SA

    10/2/24 2:26:00 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care
    Get the next $AUNA alert in real time by email
    SC 13G/A 1 fp0090394-1_sc13ga.htm

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED

    PURSUANT TO RULE 13d-2(b)

     

    (AMENDMENT NO. 1)*

     

    AUNA, S.A.

    (Name of Issuer)

     

    Class A Ordinary Shares, nominal value US$0.01 per share

    (Title of Class of Securities)

     

    L0415A103

    (CUSIP Number)

     

    RWC Asset Management LLP

    Attention: Fadi Freiha

    Verde, 10 Bressenden Place

    London, SW1E 5DH

    United Kingdom

    (+44 20 7227 6000)

    (Name, Address and Telephone Number of Person

    Authorized to Receive Notices and Communications)

     

    September 30, 2024

    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    [ V ] Rule 13d-1(b)

    [ ] Rule 13d-1(c)

    [ ] Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

    CUSIP No. L0415A103   13G   Page 2 of 5 Pages

     

    1.

    NAMES OF REPORTING PERSONS OR

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    RWC Asset Management LLP

     
    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (see instructions)

    (a) [ X ]

    (b) [ ]

    3.

    SEC USE ONLY

     

     
    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

    United Kingdom

     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5.

    SOLE VOTING POWER

     

    1,521,557

    6.

    SHARED VOTING POWER

     

    00,000

    7.

    SOLE DISPOSITIVE POWER

     

    1,521,557

    8.

    SHARED DISPOSITIVE POWER

     

    00,000

    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,521,557

     
    10.

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    (see instructions) [ ]

     

     
    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    5.07%

     
    12.

    TYPE OF REPORTING PERSON (see instructions)

     

    IA

     

     

     

     

     


    CUSIP No. L0415A103   13G   Page 3 of 5 Pages

     

    Item 1. (a)

    Name of Issuer

    Auna S.A. (the Issuer)

         
      (b)

    Address of Issuer’s Principal Executive Offices

    46A, Avenue J.F. Kennedy, L-1855 Luxembourg, Grand Duchy of Luxembourg

     

    Item 2. (a)

    Name of Person Filing

    RWC Asset Management LLP

         
      (b)

    Address of the Principal Office or, if none, residence

    Verde, 10 Bressenden Place, London, SW1E 5DH, United Kingdom

         
      (c)

    Citizenship

    United Kingdom

         
      (d)

    Title of Class of Securities

    Class A Ordinary Shares, nominal value US$0.01 per share (the “Class A Shares”)

         
      (e)

    CUSIP Number

    L0415A103

     

    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

      (a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
           
      (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
           
      (c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
           
      (d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
           
      (e) [V] An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
           
      (f) [ ] An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
           
      (g) [ ] A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
           
      (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
           
      (i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
           
      (j) [ ] Group, in accordance with §240.13d-1(b)(1)(ii)(J).

     

     

     

     

    CUSIP No. L0415A103   13G   Page 4 of 5 Pages

     

    Item 4. Ownership.

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

    (a)

    Amount beneficially owned:

    As of close of business on September 30, 2024, RWC Asset Management LLP owned 1,521,557 of the Issuer’s Class A Shares, nominal value US$0.01 per share.

     
    (b)

    Percent of class:

    As of September 30, 2024, RWC Asset Management LLP owned approximately 5.07% of Issuer’s Class A Shares outstanding. This percentage is based on 30,000,000 Class A Shares outstanding as of March 21, 2024, as reported by the Issuer in the Final Prospectus.

     
    (c) Number of shares as to which the person has:  
      (i) Sole power to vote or to direct the vote: 1,521,557  
      (ii) Shared power to vote or to direct the vote: 00,000  
      (iii) Sole power to dispose or to direct the disposition of: 1,521,557  
      (iv) Shared power to dispose or to direct the disposition of: 00,000  

     

    Item 5. Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ] .

     

    Instruction. Dissolution of a group requires a response to this item.

     

    Not applicable.

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     

    Not applicable.

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

     

    Not applicable.

     

    Item 8. Identification and Classification of Members of the Group.

     

    Not applicable.

     

    Item 9. Notice of Dissolution of Group.

     

    Not applicable.

     

     

     

     

    CUSIP No. L0415A103   13G   Page 5 of 5 Pages

     

    Item 10. Certification.

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

    Signature

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

      Name of Registrant  
           
      By: RWC Asset Management LLP  
           
        /s/ Fadi Freiha  
      Name: Mr. Fadi Freiha  
      Title: Compliance Officer  
           
      Date: October 2, 2024  

     

    Get the next $AUNA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AUNA

    DatePrice TargetRatingAnalyst
    11/18/2025$6.00Overweight → Neutral
    Analyst
    5/22/2025$7.90Buy → Hold
    HSBC Securities
    4/23/2024$12.60Buy
    HSBC Securities
    4/16/2024$16.00Overweight
    JP Morgan
    4/16/2024$14.00Overweight
    Morgan Stanley
    More analyst ratings

    $AUNA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Auna Announces 3Q25 Financial Results

    Auna Delivers Solid Financial and Operating Performance in Peru and Colombia, While Advancing Key Initiatives in Mexico Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the third quarter ended September 30, 2025 ("third quarter 2025" or "3Q25"). Financial results are expressed in Peruvian Soles ("S/" or PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. 3Q25 Consolidated Highlights Consolidated Revenue increased 1% FXN, while decreasing 1% YoY on reported basis, to S/1,117 million Adjust

    11/20/25 4:45:00 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Auna Announces Strategic Collaboration with Sojitz to Expand Healthcare Access in Latin America

    Auna S.A. ("Auna" or the "Company"), a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, announced today that Auna and Sojitz Corporation of America ("Sojitz"), a global investment and trading group headquartered in Japan, have entered into a Memorandum of Understanding (MOU) to explore joint business opportunities in the healthcare sector across Latin America, with an initial focus on Mexico, one of the region's largest and fastest-growing healthcare markets. On September 24, 2025, Auna announced its intention to invest approximately US$500 million over the next three to five years to expand its integrated healthcare platform in Mexico.

    11/20/25 4:30:00 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Construction License for Torre Trecca Is Granted to EsSalud, Marking Key Milestone in Auna's Public–Private Partnership with the Institution

    Auna S.A. ("Auna" or the "Company"), a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, announced today that EsSalud, Peru's Social Security System, has formally received the construction license for Torre Trecca, a high-rise outpatient treatment center that Auna will rebuild and, upon completion, operate on behalf of EsSalud as part of an existing public–private partnership ("PPP"). When completed, Torre Trecca is expected to serve more than six million Peruvians living in the city of Lima who are insured by EsSalud and to accommodate more than three million visits annually. The license milestone was commemorated during a ceremony atten

    11/18/25 9:25:00 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    $AUNA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Auna S.A. downgraded by Analyst with a new price target

    Analyst downgraded Auna S.A. from Overweight to Neutral and set a new price target of $6.00

    11/18/25 8:17:10 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Auna S.A. downgraded by HSBC Securities with a new price target

    HSBC Securities downgraded Auna S.A. from Buy to Hold and set a new price target of $7.90

    5/22/25 10:32:04 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    HSBC Securities initiated coverage on Auna S.A. with a new price target

    HSBC Securities initiated coverage of Auna S.A. with a rating of Buy and set a new price target of $12.60

    4/23/24 6:12:32 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    $AUNA
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by Auna SA

    SCHEDULE 13D/A - AUNA S.A. (0001799207) (Subject)

    12/2/25 6:35:34 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    SEC Form 6-K filed by Auna SA

    6-K - AUNA S.A. (0001799207) (Filer)

    11/20/25 5:03:36 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    SEC Form 6-K filed by Auna SA

    6-K - AUNA S.A. (0001799207) (Filer)

    11/20/25 4:43:15 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    $AUNA
    Leadership Updates

    Live Leadership Updates

    View All

    Auna Signs Exclusive Five-Year Agreement with Leading Oncology Group to Strengthen Oncology Services in Monterrey

    Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru, and Colombia, announced today the signing of an exclusive five-year agreement with a physician group practicing at Organización Para Cuidado Integral en Oncología, S.A. de C.V. known as Opción Oncología, the premier oncology ambulatory clinic in Monterrey. This strategic partnership strengthens Auna's commitment to becoming the leading oncology provider in Mexico and marks a significant step in consolidating oncology services within Auna Mexico. As part of this agreement, eight highly regarded physicians – six oncologists and two radiation oncologists – will join Auna. Toda

    3/7/25 8:00:00 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Auna appoints Teresa Gutierrez and Guadalupe Phillips to Its Board of Directors

    Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a leading Latin American healthcare company operating in Mexico, Peru, and Colombia, today announced the appointment of two new independent directors, Teresa Gutierrez and Guadalupe Phillips, to its Board of Directors, effective January 1, 2025. Ms. Gutierrez is responsible for Tesla in Mexico. Prior to that, she held positions at Rappi, Mattel, Nestle, McKinsey, and Procter and Gamble. She serves on the boards of several public and private companies, including Traxion, DIRI, Vetalia, and Timser. Ms. Phillips is the Chief Executive Officer of ICA, a prominent construction and infrastructure company in Mexico after a long career holding se

    12/19/24 9:01:00 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Auna Appoints Executive Vice President, Strategy and Equity Capital Markets Reinforcing Its Leadership Structure

    Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the appointment of Laurent "Lorenzo" Massart as Executive Vice President, Strategy and Equity Capital Markets to its executive team. "We are thrilled to welcome Lorenzo to the Auna team. With over 25 years of experience in consulting and investment banking, he brings a wealth of knowledge and expertise to this newly created role. He has been a key and trusted advisor in our strategic endeavors and has worked closely with me and Auna for the last three years, playing an integral part of our journey into Mexico and on becoming a public company,"

    9/3/24 11:30:00 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    $AUNA
    Financials

    Live finance-specific insights

    View All

    Auna Announces 3Q25 Financial Results

    Auna Delivers Solid Financial and Operating Performance in Peru and Colombia, While Advancing Key Initiatives in Mexico Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the third quarter ended September 30, 2025 ("third quarter 2025" or "3Q25"). Financial results are expressed in Peruvian Soles ("S/" or PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. 3Q25 Consolidated Highlights Consolidated Revenue increased 1% FXN, while decreasing 1% YoY on reported basis, to S/1,117 million Adjust

    11/20/25 4:45:00 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Auna Announces Reporting Dates for Third Quarter 2025 Financial Results

    Auna S.A. (NYSE:AUNA) ("Auna" or "the Company"), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Third Quarter 2025 financial results. Earnings Release Thursday, November 20, 2025 Time: After Market Close Conference Call Friday, November 21, 2025 Time: 8:00 a.m. ET Quiet Period Thursday, November 13 through Thursday, November 20, 2025 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with ope

    10/29/25 8:30:00 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Auna Announces 2Q25 Financial Results

    Adjusted EBITDA increases 5% FXN YoY with all segments contributing positively to quarterly results in their local currency Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial results for the second quarter ended June 30, 2025 ("second quarter 2025" or "2Q25"). Financial results are expressed in Peruvian Soles ("S/" or PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. 2Q25 Consolidated Highlights Consolidated Revenue increased 4% FXN while decreasing 2% YoY on reported basis to S/1,094 million Adjuste

    8/19/25 4:15:00 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    $AUNA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Auna SA

    SC 13G - AUNA S.A. (0001799207) (Subject)

    11/14/24 2:22:37 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Auna SA

    SC 13G/A - AUNA S.A. (0001799207) (Subject)

    11/13/24 10:53:24 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by Auna SA

    SC 13G - AUNA S.A. (0001799207) (Subject)

    11/12/24 6:09:04 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care